MPLN (@molpathnet) header
MPLN (@molpathnet) profile picture

MPLN

@molpathnet

Molecular Pathology Laboratory Network, custom services for #oncologists #pathologists; experience in #flowcytometry #cytogenetics #FISH #molecular #genomics

 Maryville, TN
mplnet.com
Joined March 2016
  • Tweets264
  • Following85
  • Followers89
4Media
Photo by MPLN (@molpathnet)Photo by MPLN (@molpathnet)Photo by MPLN (@molpathnet)Photo by MPLN (@molpathnet)
Shortage of Histopathologists in the United Kingdom Now Contributing to Record-Long Cancer-Treatment Waiting Times in England darkdaily.com/shortage-of-hi…
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO/CAP Clinical Practice Guideline Focused Update 2018... archivesofpathology.org/doi/…
1
The number of men dying from prostate cancer has overtaken female deaths from breast cancer for the first time in the UK. Prostate Cancer UK finds the disease currently receives half the funding and half the research that is devoted to breast cancer.
Image from MPLN (@molpathnet)
2
2
FDA finalizes guidances to accelerate the development of reliable, beneficial next generation sequencing-based tests fda.gov/NewsEvents/Newsroom/…
1
MPLN NGS panel content is based on NCCN and updated WHO practice guidelines. Oncogenic driver mutations significantly impact prognosis and management in MPNs, and mutations may also serve as diagnostically useful markers of clonality. mplnet.com/services/genomics…
1
1
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors. ncbi.nlm.nih.gov/pubmed/2935…
Next generation sequencing offers significant advantages in the evaluation of IgVH somatic hypermutation status in CLL/SLL mplnet.com/services/genomics…
clpmag.com/2018/03/inside-tr…
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From CAP, the International Association for the Study of Lung Cancer, and AMP. ncbi.nlm.nih.gov/pubmed/2939…
the-scientist.com/?articles.… “the results really bring home the message that pediatric cancer patients are not small adults,”
1
2
Novartis CAR-T cell therapy CTL019 receives FDA Breakthrough Therapy designation for Tx of adults with r/r DLBCL novartis.com/news/media-rele…
1
Review @JCO_ASCO, Childhood Brain Tumors: Genome-Wide Discovery and Precision Medicine ascopubs.org/doi/pdf/10.1200…
1
#LungCancer genomic testing is underutilized. Is #liquidbiopsy the answer? @GenomeWeb nitter.gq/GenomeWeb/status/87946…
GenomeWeb (@GenomeWeb) profile pictureGenomeWeb@GenomeWeb26 Jun 2017
Lung cancer is on the front lines of #LiquidBiopsy adoption, but test proliferation poses challenges for clinicians ow.ly/BCUa30cUoAT
Recent Breast Cancer HER2 Testing Guideline Update Produces Similar Positivity Rate @JournalofCP shar.es/1Bul7T
PD-L1 Testing Uncommon Among NSCLC Patients on #immunotherapy #LungCancer @JournalofCP shar.es/1BuJFx
Study following ASCUS, 16.0% more CIN3+ lesions detected with HPV testing, and time to CIN3+ detection shorter. nitter.gq/JAMAOnc/status/8779191…
JAMA Oncology (@JAMAOnc) profile pictureJAMA Oncology@JAMAOnc22 Jun 2017
HPV testing of women leads to faster & more complete diagnosis of cervical dzs, but more biopsies ja.ma/2sUbI6k #GynCSM
Join Dr.Tandon's workshop today: 13th International Conference on Pathology and Molecular Diagnostics in San Diego. bit.ly/2s3CaW4
B.Tandon MD. presents workshop: Contemporary Genomic studies in hematologic #pathology: #nextgenerationsequencing bit.ly/2s3CaW4
1
Dr. Bevan Tandon presents workshop: 13th Int.Conference on Pathology and Molecular Diagnosis June 27th in San Diego bit.ly/2symIVj
1
FDA has granted orphan drug designation for the treatment of soft tissue sarcoma @EpizymeRx bit.ly/2sFk0Mo
Load more